Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2015, Issue 6, 2015, Pages 53-62

  Krupitsky, E M ^a   Rybakova, K V ^a   Kiselev, A S ^a   Alexeeva, Yu V ^a   Berntsev, V A ^a   Chekhlaty, E I ^a   Zubova, E Yu ^a   Popov, Yu V ^a   Neznanov, N G ^a  

^a Bekhterev St Petersburg Psychoneurological Research Institute   (Russian Federation)

Author keywords

Alcohol dependence; Baclofen; Treatment of alcoholism

Indexed keywords

BACLOFEN; LIVER ENZYME; PLACEBO; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALCOHOL;

ALCOHOLISM; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HAMILTON ANXIETY SCALE; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATE TRAIT ANXIETY INVENTORY; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME; ADOLESCENT; ADULT; AGED; DRINKING BEHAVIOR; FEMALE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PILOT STUDY; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; ANXIETY; BACLOFEN; DEPRESSION; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84946151748     PISSN: 19977298     EISSN: 23094729     Source Type: Journal    
DOI: 10.17116/jnevro20151156153-62     Document Type: Article

References (26)

1. Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev. 2004;84:835–867. doi: 10.1152/physrev.00036.
2. Couve A, Calver AR, Fairfax B, Moss SJ, Pangalos MN. Unravelling the unusual signalling properties of the GABAB receptor. Biochem Pharmacol. 2004;68:1527-1536. doi: 10.1016/j.bcp.2004.06.036.
3. Emson PC. GABAB receptors: structure and function in GABA and the Basal Ganglia, Progress in Brain Research. Eds. Tepper JM, Abercrombie ED, Bolam JP. Amsterdam: Elsevier; 2007;160:43-57. doi: 10.1016/s0079-6123(06)60004-6.
4. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30:228-235. doi: 10.1016/j.tins.2007.03.008.
5. Waraczynski M, Salemme J, Farral B. Brain stimulation reward is affected by D2 dopamine receptor manipulations in the extended amygdala but not the nucleus accumbens. Behav Brain Res. 2010;208:2:626-635. doi: 10.1016/j.bbr.2010.01.009.
6. Leite-Morris KA. The effects of ventral tegmental baclofen on ethanolinduced motor stimulation and sensitization in DBA/2 mice. Alcohol Clin Exp Res. 2004;28:182.
7. Pitman KA, Puil E, Borgland SL. GABAB modulation of dopamine release in the nucleus accumbens core. Eur J Neurosci. 2014;40(10):3472-3480. doi: 10.1111/ejn.12733.
8. Corrigall WA, Coen KM, Adamson KL, Chow BL, Zhang J. Response of nicotine selfadministration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology. 2000;149:107-114. doi: 10.1007/s002139900355.
9. Fattore L, Cossu G, Martellotta MC, Fratta W. Baclofen antagonizes intravenous selfadministration of nicotine in mice and rats. Alcohol Alcohol. 2002;37:495-498. doi: 10.1093/alcalc/37.5.495.
10. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF. Animal models of drug craving. Psychopharmacology. 1993;112:163-182. doi: 10.1007/bf02244907.
11. Paterson NE, Froestl W, Markou A. The GABAB receptor agonists baclofen and CGP44532 decrease nicotine self-administration in the rat. Psychopharmacology (Berl). 2004;172(2):179-186. doi: 10.1007/s00213-003-1637-1.
12. Shoaib M, Swanner LS, Beyer CE, Goldberg SR, Schindler CW. The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol. 1998;9:195-206. doi: 10.1097/00008877-199605001-00238.
13. Krupitsky EM, Burakov AM, Ivanov VB, Krandashova GF, Lapin IP, Grienko AJ, Borodkin YS. Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend. 1993;33:157-163. doi: 10.1016/0376-8716(93)90057-w.
14. Evans SM, Bisaga A. Acute Interaction of Baclofen in Combination with Alcohol in Heavy Social Drinkers. Alcohol Clin Exp Res. 2009;33(1):19-30. doi: 10.1111/j.1530-0277.2008.00805.x.
15. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D’Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, doubleblind controlled study. Lancet. 2007;370:1915-1922. doi: 10.1016/s0140-6736(07)61814-5.
16. Garbutt JC, Kampov-Polevoy AB, Gallop R et al. Efficacy and safety of baclofen for alcohol dependence: A randomized, double-blind, placebocontrolled trial. Alcohol Clin Exp Res. 2010;34(11):1849-1857. doi: 10.1111/j.1530-0277.2010.01273.x.
17. de Beaurepaire R. Suppression of alcohol dependence using baclofen:a 2-year observational study of 100 patients. Front Psychiatry. 2012;3:103. doi:10.3389/fpsyt.2012.00103.
18. Rigal L, Alexandre-Dubroeucq C, de Beaurepaire R, Le Jeunne C, Jaury P. Abstinence and «low-risk» consumption 1 year after the initiation ofhighdose baclofen: a retrospective study among «high-risk» drinkers. Alcohol Alcohol. 2012;47:439-442. doi: 10.1093/alcalc/ags028.
19. Sobell MB, Sobell LC, Klajner F, Pavan D. The reliability of a timeline method for assessing normal drinker college students’ recent drinking history: utility for alcohol research. Addict Behav. 1986;11:2:149-161. doi: 10.1016/0306-4603(86)90040-7.
20. Busner J, Targum SD, Miller DS. The Clinical Global Impressions Scale: Errors in Understanding and Use. Compr Psychiatry. 2009;50:3:257-262.
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296. doi: 10.1016/j.comppsych.2008.08.005.
22. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Press. 1970.
23. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. doi: 10.1192/bjp.134.4.382
24. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn alcohol craving scale. Alc Clin Exp Res. 1999;23:8:1289-1295. doi: 10.1111/j.1530-0277.1999.tb04349.x.
25. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale. Arch Gen Psych. 1996;53:3:225-231. doi: 10.1001/archpsyc.1996.01830030047008.
26. Pettinati HM, Weiss RD, Miller WR, Dundon W. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Bethesda, MD: US Department of Health and Human Services: 2004. Monograph Series, V. 2.